COM:TMEPHARMA
TME Pharma N.V.
- Stock
locale
Germanymarket
STOCKSindustry
Biopharmaceuticalwebsite
tmepharma.comcrunchbase
noxxon-pharmalinkedin
tme-pharmaipo date
Sep 30, 2016
TME Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. Its Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, ...Show More